论文部分内容阅读
20 0 4年第 11届基于细胞测定的高通量药物筛选年会着重讨论了基于细胞筛选所取得的进展 ,并探讨了该技术相对于无细胞筛选的利弊。分子靶标的筛选 基于细胞方法已成功地应用于膜酪氨酸激酶筛选 ,该技术只用激酶区而不用完整蛋白可筛选生长因子受体酪氨酸激酶。基于细胞筛选可
The 11th Annual Cell-Assay-Based High-Throughput Drug Screening Session in 2040 focused on the advances made in cell-based screening and explored the pros and cons of this technology over cell-free screening. Screening of molecular targets has been successfully applied to membrane tyrosine kinase screening based on cellular methods that screen for growth factor receptor tyrosine kinases using only the kinase region and not the intact protein. Cell-based screening can be